Home
Conditions
Hepatitis

Clinical trial condition

Hepatitis

Explore clinical trials studying Hepatitis. Study availability and eligibility vary by location and protocol.

2,969 public trials 189 recruiting studies

Refine in advanced search Browse all conditions

Hepatitis trial results

Completed

A Retrospective Biomarker Study of Stored Samples Obtained From Patients With Chronic Hepatitis B

NCT01705704

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Herston, Queensland, Australia

Fitzroy, Victoria, Australia

Clichy, France

Hong Kong

View all 27 locations

View Trial Details

Completed

A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Ribavirin in Hemophiliac Patients With Chronic Hepatitis C.

NCT00475072

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Mexico City, Mexico

View Trial Details

Completed

HELPS Study - A Study of Peginterferon Alfa-2a (Pegasys) in Patients With Chronic Hepatitis C (CHC) and End-Stage Renal Disease (ESRD)

NCT02806505

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Graz, Austria

Vienna, Austria

Brasília, Brazil

Porto Alegre, Brazil

View all 22 locations

View Trial Details

Completed

TDF VS LAM + ADV in LAM + ADV Treated LAM-resistant CHB Patients With Undetectable Hepatitis B Virus DNA

NCT01732367

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Department of Internal Medicine, Keimyung University Dongsan Medical Center Daegu, South Korea

View Trial Details

Completed

Persistence of Hepatitis B Antibody Levels & Immune Response to a Hepatitis B Vaccine Challenge

NCT00411697

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: GSK Investigational Site Bad Saulgau, Baden-Wurttemberg, Germany

GSK Investigational Site Bietigheim-Bissingen, Baden-Wurttemberg, Germany

GSK Investigational Site Bönnigheim, Baden-Wurttemberg, Germany

GSK Investigational Site Ehingen, Baden-Wurttemberg, Germany

View all 36 locations

View Trial Details

Completed

HCV Treatment in HIV Co-Infected Patients in Asia

NCT01838772

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: Cipto Mangunkusumo General Hospital Jakarta, Indonesia

University of Malaya Medical Centre Kuala Lumpur, Malaysia

HIV-NAT/ Thai Red Cross AIDS Research Center Bangkok, Thailand

National Hospital for Tropical Diseases Hanoi, Vietnam

View Trial Details

Completed

Can Vitamin D Supplementation Improve Hepatitis C Cure Rates

NCT02053519

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: NHS Grampian Aberdeen, United Kingdom

NHS Tayside Dundee, United Kingdom

NHS Lothian Edinburgh, United Kingdom

NHS Lothian Edinburgh, United Kingdom

View Trial Details

Completed

CHLOROQUINE FOR MAINTENANCE REMISSION OF AUTOIMMUNE HEPATITIS

NCT01980745

Conditions: Autoimmune Diseases, Digestive System Diseases, Disease Attributes, +8 more
Locations: University of São Paulo School of Medicine São Paulo, Brazil

View Trial Details

Completed

Depression, Genes, Cytokines, Chronic Fatigue, Physical Illnesses and Quality of Life

NCT02943330

Conditions: Behavior, Behavioral Symptoms, Blood-Borne Infections, +12 more
Locations: Not specified

View Trial Details

Completed

A Study of Peginterferon Alfa-2a (40KD) (PEGASYS®) in Participants With Hepatitis B Envelope Antigen (HBeAg) - Positive Chronic Hepatitis B

NCT00436163

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Tallinn, Estonia

Tallinn, Estonia

Tartu, Estonia

Riga, Latvia

View Trial Details

Hepatitis

Hepatitis trial results

Related conditions